Colorectal cancer gene implicated in broad range of solid tumors

by Amy Mone, Valerie Mehl,Johns Hopkins UniversityMUTYH-altered samples. (A) CONSORT diagram showing grouping of samples. Samples with somatic MUTYH alterations including pathogenic short varian

Updated on: March 27,2024

Colorectal cancer gene implicated in broad range of solid tumors

by Amy Mone, Valerie Mehl,Johns Hopkins UniversityMUTYH-altered samples. (A) CONSORT diagram showing grouping of samples. Samples with somatic MUTYH alterations including pathogenic short varian

Updated on:March 27,2024

Researchers develop treatment that turns tumors into cancer vaccine factories

by The Mount Sinai HospitalCredit: CC0 Public DomainResearchers at Mount Sinai have developed a novel approach to cancer immunotherapy, injecting immune stimulants directly into a tumor to teach

Updated on: June 11,2024

Researchers develop treatment that turns tumors into cancer vaccine factories

by The Mount Sinai HospitalCredit: CC0 Public DomainResearchers at Mount Sinai have developed a novel approach to cancer immunotherapy, injecting immune stimulants directly into a tumor to teach

Updated on:June 11,2024

Clinical trial shows significant disease-free survival for patients diagnosed with non-small cell lung cancer

byYale UniversityDFS per investigator assessment. Kaplan-Meier estimates of duration of (A) DFS in patients with stage II-IIIA disease and (B) in the overall population (stage IB-IIIA) by sevent

Updated on: December 28,2023

Clinical trial shows significant disease-free survival for patients diagnosed with non-small cell lung cancer

byYale UniversityDFS per investigator assessment. Kaplan-Meier estimates of duration of (A) DFS in patients with stage II-IIIA disease and (B) in the overall population (stage IB-IIIA) by sevent

Updated on:December 28,2023

Clinical trial shows durvalumab plus ceralasertib boosted immune response in lung cancer patients

by University of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainA specific combination of targeted therapy and immunotherapy may better help patients with non-small cell lung

Updated on: May 09,2024

Clinical trial shows durvalumab plus ceralasertib boosted immune response in lung cancer patients

by University of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainA specific combination of targeted therapy and immunotherapy may better help patients with non-small cell lung

Updated on:May 09,2024

Exploring the role of reactive oxygen species in cellular health and disease through HyPerion

Updated on: July 17,2024

Exploring the role of reactive oxygen species in cellular health and disease through HyPerion

Updated on:July 17,2024

Understanding breast cancer recurrence, metastatic spread

byUniversity of CincinnatiCredit: Unsplash/CC0 Public DomainDespite advancements in cancer detection and treatment, breast cancer that comes back or spreads still presents a challenge to researc

Updated on: December 28,2023

Understanding breast cancer recurrence, metastatic spread

byUniversity of CincinnatiCredit: Unsplash/CC0 Public DomainDespite advancements in cancer detection and treatment, breast cancer that comes back or spreads still presents a challenge to researc

Updated on:December 28,2023

Chemically 'poisoned' protein acts as a molecular switch to spur cancer formation

byThe Scripps Research InstituteResearchers discovered that when the protein DNMT3B becomes S-nitrosylated in the presence of nitric oxide (NO), cancer-related genes become activated, leading to

Updated on: December 25,2023

Chemically 'poisoned' protein acts as a molecular switch to spur cancer formation

byThe Scripps Research InstituteResearchers discovered that when the protein DNMT3B becomes S-nitrosylated in the presence of nitric oxide (NO), cancer-related genes become activated, leading to

Updated on:December 25,2023

CAR T cell therapy targeting HER2 antigen shows promise against advanced sarcoma in clinical trial

byBaylor College of MedicineCredit: Pixabay/CC0 Public DomainResearchers at Texas Children's Cancer Center and the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Child

Updated on: April 30,2024

CAR T cell therapy targeting HER2 antigen shows promise against advanced sarcoma in clinical trial

byBaylor College of MedicineCredit: Pixabay/CC0 Public DomainResearchers at Texas Children's Cancer Center and the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Child

Updated on:April 30,2024

Cellular 'fingerprint' may offer early warning of cancer risk

by Isabella Backman,Yale UniversityCellDRIFT is turned back upon reprogramming in human fibroblasts, but is not stabilized with additional passages. (A) Scatterplot showing reprogramming traject

Updated on: January 10,2024

Cellular 'fingerprint' may offer early warning of cancer risk

by Isabella Backman,Yale UniversityCellDRIFT is turned back upon reprogramming in human fibroblasts, but is not stabilized with additional passages. (A) Scatterplot showing reprogramming traject

Updated on:January 10,2024

Bloomberg School Researchers Develop Universal Risk Predictor for Cardiovascular Disease

Universal risk predictor for cardiovascular disease, suitable for use in both primary and secondary prevention, would streamline risk assessmentPublishedJanuary 29, 2024EPIDEMIOLOGYResearchers from th

Updated on: February 18,2024

Bloomberg School Researchers Develop Universal Risk Predictor for Cardiovascular Disease

Universal risk predictor for cardiovascular disease, suitable for use in both primary and secondary prevention, would streamline risk assessmentPublishedJanuary 29, 2024EPIDEMIOLOGYResearchers from th

Updated on:February 18,2024

Treatment for recurrent uterine cancer advances to next research phase

by Yale Cancer Center/Smilow Cancer HospitalCredit: Pixabay/CC0 Public DomainThe latest trial of a new antibody drug that delivers potent chemotherapy directly to cancer cells for patients with advanc

Updated on: August 27,2024

Treatment for recurrent uterine cancer advances to next research phase

by Yale Cancer Center/Smilow Cancer HospitalCredit: Pixabay/CC0 Public DomainThe latest trial of a new antibody drug that delivers potent chemotherapy directly to cancer cells for patients with advanc

Updated on:August 27,2024

Two drugs used in combination prove to be effective against most aggressive asbestos cancer in mice

byThe Spanish National Cancer Research CentreSection of a mouse invasive mesothelioma tumour. Credit: CNIOExposure to asbestos is the major risk factor for malignant mesothelioma, a type of aggr

Updated on: December 22,2023

Two drugs used in combination prove to be effective against most aggressive asbestos cancer in mice

byThe Spanish National Cancer Research CentreSection of a mouse invasive mesothelioma tumour. Credit: CNIOExposure to asbestos is the major risk factor for malignant mesothelioma, a type of aggr

Updated on:December 22,2023